domingo, 1 de agosto de 2021

Controversy and Progress in Alzheimer's Disease - FDA Approval of Aducanumab. Rabinovici Gil D et al. The New England journal of medicine 2021 7

Main|Search|PHGKB

No hay comentarios:

Publicar un comentario